MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer

作者: Hyung Seok Kim , Kyo Sun Lee , Hyun Jin Bae , Jung Woo Eun , Qingyu Shen

DOI: 10.18632/ONCOTARGET.3512

关键词:

摘要: // Hyung Seok Kim 1,2,* , Kyo Sun Lee 3,* Hyun Jin Bae 1,2 Jung Woo Eun Qingyu Shen Se Park Chan Shin Hee Doo Yang Mijung Won Sang Yong-Koo Kang 3 and Suk Nam 1,2,4 1 Lab of Oncogenomics, Department Pathology, College Medicine, The Catholic University Korea, Seoul, Republic Korea 2 Functional RNomics Research Center, Orthopedic Surgery, Gyeonggi-do, 4 Cancer Evolution * These authors contributed equally to this work Correspondence to: Nam, email: Keywords : Hepatocellular carcinoma, microRNA-31, CDK2, HDAC2, cell cycle Received October 01, 2014 Accepted February 04, 2015 Published March 10, Abstract MicroRNA-31 (miR-31) is among the most frequently altered microRNAs in human cancers expression miR-31 has been detected a large variety tumor types, but functional role still hold both suppressive oncogenic roles different types. MiR-31 was down-regulated cohort hepatocellular carcinoma (HCC) patients, low significantly associated with poor prognosis HCC patients. Ectopic mimics suppressed growth by transcriptional deregulation proteins. Additional study evidenced directly suppress HDAC2 CDK2 inhibiting mRNA translation cells. We also found that ectopic reduced metastatic potential cells selectively regulating epithelial-mesenchymal transition (EMT) regulatory proteins such as N-cadherin, E-cadherin, vimentin fibronectin . tissues derived from chemical-induced rat liver cancer models validated down-regulated, those cycle- EMT-regulatory are deregulated cancer. Overall, we suggest functions suppressor EMT hepatocarcinogenesis providing novel target for molecular treatment malignancies.

参考文章(30)
Irfan A. Asangani, Paul W. Harms, Lois Dodson, Mithil Pandhi, Lakshmi P. Kunju, Christopher A. Maher, Douglas R. Fullen, Timothy M. Johnson, Thomas J. Giordano, Nallasivam Palanisamy, Arul M. Chinnaiyan, Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma Oncotarget. ,vol. 3, pp. 1011- 1025 ,(2012) , 10.18632/ONCOTARGET.622
Eeva M. Laurila, Anne Kallioniemi, The diverse role of miR‐31 in regulating cancer associated phenotypes Genes, Chromosomes and Cancer. ,vol. 52, pp. 1103- 1113 ,(2013) , 10.1002/GCC.22107
Sergey V. Ivanov, Chandra M. V. Goparaju, Peter Lopez, Jiri Zavadil, Ginat Toren-Haritan, Shai Rosenwald, Moshe Hoshen, Ayelet Chajut, Dalia Cohen, Harvey I. Pass, Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma Journal of Biological Chemistry. ,vol. 285, pp. 22809- 22817 ,(2010) , 10.1074/JBC.M110.100354
Scott Valastyan, Ferenc Reinhardt, Nathan Benaich, Diana Calogrias, Attila M Szász, Zhigang C Wang, Jane E Brock, Andrea L Richardson, Robert A Weinberg, None, RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis Cell. ,vol. 137, pp. 1032- 1046 ,(2009) , 10.1016/J.CELL.2009.03.047
Yi Zhang, Yang Li, Changwei Lin, Jie Ding, Guoqing Liao, Bo Tang, Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma PLoS ONE. ,vol. 9, pp. e107251- ,(2014) , 10.1371/JOURNAL.PONE.0107251
P. Pineau, S. Volinia, K. McJunkin, A. Marchio, C. Battiston, B. Terris, V. Mazzaferro, S. W. Lowe, C. M. Croce, A. Dejean, miR-221 overexpression contributes to liver tumorigenesis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 264- 269 ,(2010) , 10.1073/PNAS.0907904107
Fanyin Meng, Roger Henson, Hania Wehbe–Janek, Kalpana Ghoshal, Samson T. Jacob, Tushar Patel, MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology. ,vol. 133, pp. 647- 658 ,(2007) , 10.1053/J.GASTRO.2007.05.022
C.-J. Liu, M.-M. Tsai, P.-S. Hung, S.-Y. Kao, T.-Y. Liu, K.-J. Wu, S.-H. Chiou, S.-C. Lin, K.-W. Chang, miR-31 Ablates Expression of the HIF Regulatory Factor FIH to Activate the HIF Pathway in Head and Neck Carcinoma Cancer Research. ,vol. 70, pp. 1635- 1644 ,(2010) , 10.1158/0008-5472.CAN-09-2291
Matthew F. Wszolek, Kimberly M. Rieger-Christ, Patrick A. Kenney, Justin J. Gould, Brasil Silva Neto, Amanda K. LaVoie, Tanya Logvinenko, John A. Libertino, Ian C. Summerhayes, A MicroRNA expression profile defining the invasive bladder tumor phenotype Urologic Oncology: Seminars and Original Investigations. ,vol. 29, pp. 794- 801.e1 ,(2011) , 10.1016/J.UROLONC.2009.08.024